Nuclear medicine generator to be taken to the world

Gentech, the Australian-designed technetium-99m radiopharmaceutical generator that was developed by ANSTO, is to be promoted internationally following its acceptance as part of the Australian Technology Showcase (ATS).

The generator is designed to deliver technetium, which is used in more than 70% of nuclear medicine procedures worldwide. This workhorse of nuclear medicine produces images of the brain, lungs, kidneys, liver, spleen, gall bladder and skeleton and of the cardiovascular system.

Technitium is injected into the patient with a carrier substance chosen specifically to zero in on the part of the body to be scanned. Technetium emits gamma radiation, which is detected by special cameras.

The Gentech generator was accepted to become part of the ATS scheme by the NSW Innovation Council for its potential for worldwide sales, and will now be demonstrated internationally on a range of promotional materials. The generator has the advantages of simplified technology and being easy to transport.

Item provided courtesy of ANSTO